Publications | Lund University Publications

1 – 8 of 8

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Linder%2C+O%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Linder%2C+O%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2016
Mark Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009
Rosengren, S. ; Mellqvist, U. H. ; Nahi, H. ; Forsberg, K. ; Lenhoff, S. ^LU ; Strömberg, O. ; Ahlberg, L. ; Linder, O. and Carlson, K. (2016) In Bone Marrow Transplantation 51(12). p.1569-1572
- Contribution to journal › Article
2015
Mark Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.
Gimsing, P ; Hjertner, Ø ; Abildgaard, N ; Andersen, N F ; Dahl, T G ; Gregersen, H ; Klausen, T W ; Mellqvist, U-H ; Linder, O and Lindås, R , et al. (2015) In Bone Marrow Transplantation 50(10). p.1306-1311
- Contribution to journal › Article
2009
Mark Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy
Groevdal, M. ; Kahn, R. ; Jansson, M. ; Aggerholm, A. ; Antunovic, P. ; Astermark, Jan ^LU ; Bernell, P. ; Engstroem, L. ; Kjeldsen, L. and Linder, O. , et al. (2009) 10th International Symposium on Myelodysplastic Syndromes In Leukemia Research 33(Suppl 1). p.49-50
- Contribution to journal › Published meeting abstract
2005
Mark Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience
Hallbook, H ; Hagglund, H ; Stockelberg, D ; Nilsson, Per-Gunnar ^LU ; Karlsson, Karin ^LU ; Bjorkholm, M ; Linderholm, M ; Wahlin, A ; Linder, O and Smedmyr, B (2005) In Bone Marrow Transplantation 35(12). p.1141-1148
- Contribution to journal › Article
Mark Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: Long-term follow-up
Simonsson, B ; Oberg, G ; Bjoreman, M ; Bjorkholm, M ; Carneskog, J ; Karlsson, K ; Gahrton, G ; Grimfors, G ; Hast, R and Karle, H , et al. (2005) In Acta Haematologica 113(3). p.155-162
- Contribution to journal › Article
2004
Mark Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival
Olsson-Stromberg, U ; Simonsson, B ; Ahlgren, T ; Bjorkholm, M ; Carlsson, K ; Gahrton, G ; Hast, R ; Lofvenberg, E ; Linder, O and Ljungman, P , et al. (2004) In The Hematology Journal 5(6). p.462-466
- Contribution to journal › Article
2003
Mark A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor: significant effects on quality of life
Hellstrom-Lindberg, E ; Gulbrandsen, N ; Lindberg, G ; Ahlgren, T ; Dahl, IMS ; Dybedal, I ; Grimfors, G ; Hesse-Sundin, E ; Hjorth, M and Kanter-Lewensohn, L , et al. (2003) In British Journal of Haematology 120(6). p.1037-1046
- Contribution to journal › Article
2002
Mark Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase - a report from the Swedish CML Group
Turesson, Ingemar ^LU ; Axdorph, U ; Vilen, L ; Stenke, L ; Uden, AM ; Grimfors, G ; Bjorkholm, M ; Carneskog, J ; Hansen, J and Linder, O , et al. (2002) In British Journal of Haematology 118(4). p.1048-1054
- Contribution to journal › Article

your query:: Remove author: Linder, O